Gieth Alahdab

Dr. Gieth Alahdab


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
MKMin Young Kim
Min Young Kim
NKNandini Koneru
Nandini Koneru
GAGieth Alahdab
Gieth Alahdab
MRMichael Risner
Michael Risner
AIAhmed Ibrahim
Ahmed Ibrahim
Mohamed Al-ShabraweyMohamed Al-Shabrawey
Mohamed Al-Shabrawey
Traumatic optic neuropathy (TON) causes vision loss through compression and contusion, yet there is no consensus on the most effective treatment. Polyunsaturated fatty acid (PUFA)-derived bioactive lipids metabolized by lipoxygenase (LOX), cytochrome P450 (CYP), and cyclooxygenase (COX) enzymes are known mediators of inflammation and neurodegeneration. However, their role in TON-related retinal pathology remains unclear. Controlled orbital impact (COI) was used to induce unilateral TON in mice with controlled velocity (2–3 m/s), with the fellow eye serving as an internal control. Retina tissues were collected three days post-injury and analyzed by LC/MS to quantify bioactive lipid metabolites from ω−6 and ω−3 PUFAs. Statistical analysis was performed using paired, nonparametric Wilcoxon signed-rank tests with Benjamini–Hochberg false discovery rate (FDR) correction. Results showed that among 38 reliably detected metabolites, no individual lipid showed a statistically significant difference between TON and control eyes after FDR correction (q < 0.05). However, both individual and pathway-level analysis revealed consistent trends toward increased expression of LOX- and CYP-derived metabolites across FDA PUFA substrates, including arachidonic acid (AA), linoleic acid (LA), and docosahexaenoic acid (DHA). These findings support further investigation into lipid-mediated inflammation in TON and its potential as a therapeutic target, particularly through expanding both the sample size and the post-TON time periods.

15 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GAGieth Alahdab
Gieth Alahdab
SSSonali Sharma
Sonali Sharma
NKNandini Koneru
Nandini Koneru
MMMohamed Moustafa
Mohamed Moustafa
PLPurwatiningsih Lisdiono
Purwatiningsih Lisdiono
Mohamed Al-ShabraweyMohamed Al-Shabrawey
Mohamed Al-Shabrawey
This study investigated retinal proteomic alterations associated with type-1 diabetes mellitus (T1DM) using two mouse models of diabetic retinopathy (DR): the genetic Ins2akita/+ (Akita) model and streptozotocin (STZ)-induced diabetes. Retinas were collected from Akita (n=4) and STZ-induced diabetic mice (n=6) 15–16 weeks after diabetes onset and compared with age-matched controls. Quantitative mass spectrometry identified 7,933 proteins in Akita retinas and 7,399 proteins in STZ retinas. Differentially expressed proteins were identified using adjusted p-values and log₂ fold-change, ranked by Man-hattan distance, and visualized with volcano plots and heatmaps. The top 20 dysregulat-ed proteins in each model were subjected to canonical pathway analysis. Both models demonstrated upregulation of inflammatory and angiogenesis-associated proteins, in-cluding LRRC58, coronin-2A, S100-A4, and COL4A2, supporting a pro-inflammatory and vascular remodeling microenvironment. However, there were distinctive changes in some proteins between the two models. For example, Crystallins were downregulated in the STZ model but upregulated in the Akita model. Canonical pathway analysis revealed ac-tivation of platelet-related signaling pathways, enrichment of lipid metabolic networks, and significant alterations in extracellular matrix organization. These findings indicate coordinated inflammatory, metabolic, and structural remodeling in DR and identify can-didate molecular pathways for further investigation and therapeutic targeting.

10 September 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
GAGieth Alahdab
Gieth Alahdab
SSSonali Sharma
Sonali Sharma
NKNandini Koneru
Nandini Koneru
MMMohamed Moustafa
Mohamed Moustafa
PLPurwatiningsih Lisdiono
Purwatiningsih Lisdiono
Mohamed Al-ShabraweyMohamed Al-Shabrawey
Mohamed Al-Shabrawey
This study investigated retinal proteomic alterations associated with type-1 diabetes mellitus (T1DM) using two mouse models of diabetic retinopathy (DR): the genetic Ins2akita/+ (Akita) model and streptozotocin (STZ)-induced diabetes. Retinas were collected from Akita (n = 4) and STZ-induced diabetic mice (n = 6) 15–16 weeks after the onset of diabetes and compared with age-matched controls. Quantitative mass spectrometry identified 7933 proteins in Akita retinas and 7399 proteins in STZ retinas. Differentially expressed proteins were identified using adjusted p-values and log2 fold-change, ranked by Manhattan distance, and visualized with volcano plots and heatmaps. The top 20 dysregulated proteins in each model were subjected to canonical pathway analysis. Both models demonstrated upregulation of inflammatory and angiogenesis-associated proteins, including LRRC58, coronin-2A, S100-A4, and COL4A2, supporting a pro-inflammatory and vascular remodeling microenvironment. However, several protein changes differed between the two models. For example, Crystallins were downregulated in the STZ model but upregulated in the Akita model, which were validated by western blot analysis. Canonical pathway analysis revealed activation of platelet-related signaling pathways, enrichment of lipid metabolic networks, and significant alterations in extracellular matrix organization. These findings indicate coordinated inflammatory, metabolic, and structural remodeling in DR and identify candidate molecular pathways for further investigation and therapeutic targeting.